# Sentinel Oncology Limited

## Details

- **Company number:** [05336536](https://find-and-update.company-information.service.gov.uk/company/05336536)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 19 Jan 2005
- **Registered office:** 181 SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0GJ
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COWELL, Daniel | director | 14 Mar 2011 |  |
| DIXON, John, Dr | director | 1 Feb 2010 |  |
| VENKITARAMAN, Ashok, Professor | director | 27 Mar 2006 |  |
| BOYLE, Robert George | director | 30 Jun 2005 |  |
| SIMPSON, Gavin Alexander | director | 17 May 2005 |  |
| TRAVERS, Stuart | director | 19 Jan 2005 |  |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Robert George Boyle | significant-influence-or-control | 29 Jan 2025 |  |
| Mr Stuart Travers | significant-influence-or-control | 29 Jan 2025 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | £4,721,277 | £4,684,447 | 5 |
| 31 Mar 2024 | £5,409,885 | £5,560,297 | 6 |
| 31 Mar 2023 | £2,935,753 | £3,598,219 | 5 |
| 31 Mar 2022 | £3,204,881 | £3,546,144 | 5 |
| 31 Mar 2021 | £2,680,965 | £2,706,673 | 5 |
| 31 Mar 2020 | £872,135 | £628,658 | 5 |
| 31 Mar 2019 | £722,409 | £482,773 | 4 |
| 31 Mar 2018 | £796,945 | £527,392 | 4 |
| 31 Mar 2017 | £865,085 | £719,695 | 4 |
| 31 Mar 2016 | £563,130 | £469,220 | - |
| 31 Mar 2015 | £687,403 | £612,651 | - |
| 31 Mar 2013 | £64,696 | £54,237 | - |
| 31 Mar 2012 | -£1,188,980 | £194,077 | - |
| 31 Mar 2011 | -£1,462,583 | £138,179 | - |




## Controls

- [Apherion Therapeutics Limited](/company/16879736) (16879736)



## Directors' other companies

- [DIXON, John, Dr](/person/6477259) - director at [J D International Consulting Limited](/company/06656451)